Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Kanga

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Chest|October 1, 1996
Dornase alfa therapy in cystic fibrosis: who should get it?J F Kanga
Clinical Pediatrics|October 1, 1988
Pneumoparotid. In cystic fibrosisM L David, J F Kanga
Pediatric Pulmonology|September 1, 1986
Comparison of the lung sound frequency spectra of infants and adultsJ F Kanga, S S Kraman
Radiographics : a Review Publication of the Radiological Society of North America, Inc|March 1, 1994
Congenital pulmonary venolobar syndrome revisitedJ H Woodring, T A Howard, J F Kanga
Pediatric Pulmonology|November 1, 1992
The clinical and imaging spectrum of findings in patients with congenital lobar emphysemaK B Stigers, J H Woodring, J F Kanga
Clinical Physiology (Oxford, England)|August 1, 1988
Does airway closure affect lung sound generation?A B Bohadana, J F Kanga, S S Kraman
Critical Care Medicine|July 1, 1982
A simple device for calculation of continuous infusions of isoproterenol in childrenJ F Kanga, S J Tilden, W W Waring
Chest|March 1, 1991
Changes in left ventricular diastolic filling patterns by Doppler echocardiography in cystic fibrosisG L Johnson, J F Kanga, C B Moffett, et al.
The Pediatric Infectious Disease Journal|January 1, 1997
Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study GroupD A Church, J F Kanga, R J Kuhn, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Chest|October 1, 1996
Dornase alfa therapy in cystic fibrosis: who should get it?J F Kanga
Clinical Pediatrics|October 1, 1988
Pneumoparotid. In cystic fibrosisM L David, J F Kanga
Pediatric Pulmonology|September 1, 1986
Comparison of the lung sound frequency spectra of infants and adultsJ F Kanga, S S Kraman
Radiographics : a Review Publication of the Radiological Society of North America, Inc|March 1, 1994
Congenital pulmonary venolobar syndrome revisitedJ H Woodring, T A Howard, J F Kanga
Pediatric Pulmonology|November 1, 1992
The clinical and imaging spectrum of findings in patients with congenital lobar emphysemaK B Stigers, J H Woodring, J F Kanga
Clinical Physiology (Oxford, England)|August 1, 1988
Does airway closure affect lung sound generation?A B Bohadana, J F Kanga, S S Kraman
Critical Care Medicine|July 1, 1982
A simple device for calculation of continuous infusions of isoproterenol in childrenJ F Kanga, S J Tilden, W W Waring
Chest|March 1, 1991
Changes in left ventricular diastolic filling patterns by Doppler echocardiography in cystic fibrosisG L Johnson, J F Kanga, C B Moffett, et al.
The Pediatric Infectious Disease Journal|January 1, 1997
Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study GroupD A Church, J F Kanga, R J Kuhn, et al.
Pageof 1